GH Research Plc (GHRS)
22.94
+0.08
(+0.35%)
USD |
NASDAQ |
Oct 02, 16:00
22.93
-0.01
(-0.04%)
After-Hours: 20:00
GH Research Enterprise Value : 1.212B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.212B |
| October 01, 2026 | 1.207B |
| September 30, 2026 | 1.249B |
| September 29, 2026 | 1.331B |
| September 28, 2026 | 1.245B |
| September 25, 2026 | 1.274B |
| September 24, 2026 | 1.316B |
| September 23, 2026 | 1.420B |
| September 22, 2026 | 1.550B |
| September 21, 2026 | 1.555B |
| September 18, 2026 | 1.578B |
| September 17, 2026 | 1.609B |
| September 16, 2026 | 1.543B |
| September 15, 2026 | 1.529B |
| September 14, 2026 | 1.552B |
| September 11, 2026 | 1.505B |
| September 10, 2026 | 1.510B |
| September 09, 2026 | 1.529B |
| September 08, 2026 | 1.545B |
| September 04, 2026 | 1.575B |
| September 03, 2026 | 1.554B |
| September 02, 2026 | 1.564B |
| September 01, 2026 | 1.516B |
| August 31, 2026 | 1.490B |
| August 28, 2026 | 1.556B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.604B |
| August 26, 2026 | 1.629B |
| August 25, 2026 | 1.623B |
| August 24, 2026 | 1.567B |
| August 21, 2026 | 1.582B |
| August 20, 2026 | 1.606B |
| August 19, 2026 | 1.683B |
| August 18, 2026 | 1.679B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.662B |
| August 13, 2026 | 1.573B |
| August 12, 2026 | 1.713B |
| August 11, 2026 | 1.634B |
| August 10, 2026 | 1.665B |
| August 07, 2026 | 1.716B |
| August 06, 2026 | 1.741B |
| August 05, 2026 | 1.637B |
| August 04, 2026 | 1.637B |
| August 03, 2026 | 1.573B |
| July 31, 2026 | 1.564B |
| July 30, 2026 | 1.586B |
| July 29, 2026 | 1.558B |
| July 28, 2026 | 1.557B |
| July 27, 2026 | 1.543B |
| July 24, 2026 | 1.510B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.122T |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 17.48B |
| Cosmo NV | -- |
| Johnson & Johnson | 644.86B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.2276 |
| Earnings Yield | -4.30% |
| Normalized Earnings Yield | -4.704 |